Loading clinical trials...
Loading clinical trials...
This study examines the feasibility and acceptability of a digital dialectical behavior therapy (d-DBT) intervention for youth at clinical high risk (CHR) for psychosis. The study aims to assess the a...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Centre for Addiction and Mental Health
NCT07226895 · Clinical High Risk for Psychosis (CHR)
NCT05968560 · Clinical High Risk for Psychosis (CHR)
NCT05509998 · First Episode Psychosis (FEP), Clinical High Risk for Psychosis (CHR)
NCT06909422 · Schizophrenia, Clinical High Risk for Psychosis (CHR)
Centre for Addiction and Mental Health
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions